U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146100) titled 'Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection' on Aug. 19.
Brief Summary: This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Study Start Date: Aug. 21
Study Type: OBSERVATIONAL
Condition:
Chronic Hepatitis B
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ausper Biopharma Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....